Zentalis Pharmaceuticals ... (ZNTL)

ZNTL trades at $1.61, 7.3% above the near-term max pain of $1.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($1-$2.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ZNTL shows a downward trend from 2.5 to 1, indicating bearish sentiment or hedging activity. The 80% spread signals divergent expectations across timeframes. Levels distributed around 1.61. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.